<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35524917</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1559-0720</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>07</Day>
            </PubDate>
          </JournalIssue>
          <Title>Biological trace element research</Title>
          <ISOAbbreviation>Biol Trace Elem Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antioxidant Capacity Is Decreased in Wilson's Disease and Correlates to Liver Function.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12011-022-03277-5</ELocationID>
        <Abstract>
          <AbstractText>The metabolic disorder Wilson's disease (WD) is caused by copper accumulation in the tissues due to a biallelic pathogenic mutation of the gene ATP7B, encoding intracellular copper transporter ATPase-7B. As copper is a redox active metal; aberrations in its homeostasis may create favourable conditions for superoxide-yielding redox cycling and oxidative damage to the cells. We tried to characterise antioxidant defence in WD patients and to evaluate whether it is related to liver function. The blood glutathione concentration, the activity of manganese-SOD (MnSOD), catalase (Cat), glutathione peroxidase, and glutathione S-transferase glutathione (GST), and serum antioxidant potential (AOP-450) were measured in WD treatment-naive patients and healthy controls and correlated with clinical data. The blood glutathione concentration, the activity of MnSOD, Cat, glutathione peroxidase, and GST and AOP-450 are significantly decreased in WD patients. There was a positive correlation of AOP-450 with AST. Moreover, the Cat and GST activity as well as AOP-450 strongly correlated with parameters of synthetic liver function. MnSOD activity correlated positively with ALT and AST.The blood glutathione concentration, the activity of MnSOD, Cat, glutathione peroxidase, and GST and AOP-450 are significantly decreased in WD patients. There was a positive correlation of AOP-450 with AST. Moreover, the Cat and GST activity as well as AOP-450 strongly correlated with parameters of synthetic liver function. MnSOD activity correlated positively with ALT and AST. Liver injury in course of WD is linked with decreased antioxidant capacity.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Gromadzka</LastName>
            <ForeName>Grażyna</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Cardinal Stefan Wyszyński University in Warsaw, Collegium Medicum, Wóycickiego 1/3, 01-938, Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Przybyłkowski</LastName>
            <ForeName>Adam</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-5851-2856</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Gastroenterology and Internal Medicine, Medical University in Warsaw, Banacha 1a, 02-097, Warsaw, Poland. aprzybylkowski@interia.pl.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Litwin</LastName>
            <ForeName>Tomasz</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Second Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego 9, 02-957, Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Karpińska</LastName>
            <ForeName>Agata</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Clinical and Experimental Pharmacology, Medical University of Warsaw, Żwirki i Wigury 81, 02-091, Warsaw, Poland.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Biol Trace Elem Res</MedlineTA>
        <NlmUniqueID>7911509</NlmUniqueID>
        <ISSNLinking>0163-4984</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Antioxidant capacity</Keyword>
        <Keyword MajorTopicYN="N">Copper</Keyword>
        <Keyword MajorTopicYN="N">Oxidative stress</Keyword>
        <Keyword MajorTopicYN="N">Wilson’s disease</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>11</Hour>
          <Minute>20</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35524917</ArticleId>
        <ArticleId IdType="doi">10.1007/s12011-022-03277-5</ArticleId>
        <ArticleId IdType="pii">10.1007/s12011-022-03277-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ala A et al (2007) Wilson’s disease. Lancet 369(9559):397–408</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(07)60196-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bitter RM et al. (2022) Structure of the Wilson disease copper transporter ATP7B. Sci Adv 8(9): p. eabl5508.</Citation>
        </Reference>
        <Reference>
          <Citation>Wallace DF, Dooley JS (2020) ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease. Hum Genet 139(8):1065–1075</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00439-020-02161-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boga S, Ala A, Schilsky ML (2017) Hepatic features of Wilson disease. Handb Clin Neurol 142:91–99</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/B978-0-444-63625-6.00009-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferenci P et al (2007) Late-onset Wilson’s disease. Gastroenterology 132(4):1294–8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2007.02.057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferenci P et al (2019) Age and sex but not ATP7B genotype effectively influence the clinical phenotype of wilson disease. Hepatology 69(4):1464–1476</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.30280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J et al (2020) The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Arch 472(10):1415–1429</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00424-020-02412-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ercal N, Gurer-Orhan H, Aykin-Burns N (2001) Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 1(6):529–39</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1568026013394831</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jomova K, Valko M (2011) Advances in metal-induced oxidative stress and human disease. Toxicology 283(2–3):65–87</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tox.2011.03.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flora SJ, Shrivastava R, Mittal M (2013) Chemistry and pharmacological properties of some natural and synthetic antioxidants for heavy metal toxicity. Curr Med Chem 20(36):4540–74</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/09298673113209990146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pisoschi AM, Pop A (2015) The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem 97:55–74</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejmech.2015.04.040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ali SS et al (2020) Understanding oxidants and antioxidants: classical team with new players. J Food Biochem 44(3):e13145</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31960481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gaetke LM, Chow CK (2003) Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 189(1–2):147–63</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0300-483X(03)00159-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yucel EM et al (2021) Investigation of dynamic thiol/disulfide homeostasis and nitrosative stress in patients with Wilson disease. Turk J Gastroenterol 32(9):765–773</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5152/tjg.2021.20549</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogihara H et al (1995) Plasma copper and antioxidant status in Wilson’s disease. Pediatr Res 37(2):219–26</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1203/00006450-199502000-00016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagasaka H et al (2006) Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson disease: hepatic manifestation in Wilson disease as a consequence of augmented oxidative stress. Pediatr Res 60(4):472–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1203/01.pdr.0000238341.12229.d3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagasaka H et al (2012) Fatty liver and anti-oxidant enzyme activities along with peroxisome proliferator-activated receptors gamma and alpha expressions in the liver of Wilson’s disease. Mol Genet Metab 107(3):542–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ymgme.2012.08.004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nagasaka H, Takayanagi M, Tsukahara H (2009) Children’s toxicology from bench to bed--liver injury (3): oxidative stress and anti-oxidant systems in liver of patients with Wilson disease. J Toxicol Sci 34(Suppl 2): p. SP229-36</Citation>
        </Reference>
        <Reference>
          <Citation>Bruha R et al (2012) Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms. J Inherit Metab Dis 35(3):541–8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10545-011-9422-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferenci P et al (2003) Diagnosis and phenotypic classification of Wilson disease. Liver Int 23(3):139–42</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1034/j.1600-0676.2003.00824.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kitzberger R, Madl C, Ferenci P (2005) Wilson disease. Metab Brain Dis 20(4):295–302</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11011-005-7910-8</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gromadzka G et al (2005) Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson’s disease. Clin Genet 68(6):524–32</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1399-0004.2005.00528.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gromadzka G et al (2010) Middle-aged heterozygous carriers of Wilson’s disease do not present with significant phenotypic deviations related to copper metabolism. J Genet 89(4):463–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12041-010-0065-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ravin HA (1961) An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med 58:161–8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13739892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rossi L et al (2006) Copper imbalance and oxidative stress in neurodegeneration. Ital J Biochem 55(3–4):212–21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17274527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamoto H et al (2001) In vivo evidence for accelerated generation of hydroxyl radicals in liver of Long-Evans Cinnamon (LEC) rats with acute hepatitis. Free Radic Biol Med 30(5):547–54</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0891-5849(00)00496-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jimenez I et al (2002) Chronic exposure of HepG2 cells to excess copper results in depletion of glutathione and induction of metallothionein. Toxicol In Vitro 16(2):167–75</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0887-2333(01)00117-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mukhopadhyay CK, Attieh ZK, Fox PL (1998) Role of ceruloplasmin in cellular iron uptake. Science 279(5351):714–7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.279.5351.714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamakura F et al (2007) In vitro preparation of iron-substituted human manganese superoxide dismutase: possible toxic properties for mitochondria. Free Radic Biol Med 43(3):423–30</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2007.04.024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li S et al (2015) The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci 16(11):26087–124</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms161125942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dalgic B et al (2005) Evaluation of oxidant stress in Wilson’s disease and non-Wilsonian chronic liver disease in childhood. Turk J Gastroenterol 16(1):7–11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16252181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalita J et al (2020) Adjunctive antioxidant therapy in neurologic Wilson’s disease improves the outcomes. J Mol Neurosci 70(3):378–385</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12031-019-01423-8</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
